Screening blood donors for hepatitis C virus: the challenge to consider cost-effectiveness.

about

Screening blood donors for hepatitis C virus: the challenge to consider cost-effectiveness.

Item

http://www.wikidata.org/entity/Q44878545

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Screening blood donors for hep ...... o consider cost-effectiveness.

@en

Screening blood donors for hep ...... o consider cost-effectiveness.

@nl

type

Item

label

Screening blood donors for hep ...... o consider cost-effectiveness.

@en

Screening blood donors for hep ...... o consider cost-effectiveness.

@nl

prefLabel

Screening blood donors for hep ...... o consider cost-effectiveness.

@en

Screening blood donors for hep ...... o consider cost-effectiveness.

@nl

P1476

Screening blood donors for hep ...... o consider cost-effectiveness.

@en

P2093

Philip Kiely

http://www.w3.org/2001/XMLSchema#string

P2860

New perspectives in occult hepatitis C virus infection

Transfusion transmission of HCV, a long but successful road map to safety

The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis

The clinical relevance of persistent recombinant immunoblot assay-indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling.

Laboratory diagnostics for hepatitis C virus infection.

Current testing strategies for hepatitis C virus infection in blood donors and the way forward

Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.

A model of the health and economic impact of posttransfusion hepatitis C: application to cost-effectiveness analysis of further expansion of HCV screening protocols.

Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.

Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios.

P304

1143-1146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1111/TRF.13127

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26074174

http://www.w3.org/2001/XMLSchema#string